Wer erbt was? - Genetik der primären Hypertonie

Hypertonie - Genetik - Kandidatengene - Pharmakogenetik

hypertension - genetics - candidate genes - pharmacogenetics

Literatur

• 1 Kannel W B. Blood pressure as a cardiovascular risk factor: prevention and treatment.  JAMA. 1996;  275 571-576
• 2 Kuznetsova T, Staessen J A, Thijs L. et al . Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion.  Circulation. 2004;  110 2644-2650
• 3 MacMahon S, Peto R, Cutler J. et al . Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.  Lancet. 1990;  335 765-774
• 4 Meyer U A. Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.  Nat Rev Genet. 2004;  5 669-676
• 5 Meyer U A. Pharmacogenetics and adverse drug reactions.  Lancet. 2000;  356 1667-1671
• 6 Sacks F M, Svetkey L P, Vollmer W M. et al. for the DASH-Sodium Collaborative Research Group . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.  N Engl J Med. 2001;  344 3-10
• 7 Staessen J A, Wang J, Bianchi G, Birkenhäger W H. Essential hypertension.  Lancet. 2003;  361 1629-1641
• 8 Staessen J A, Wang J G, Brand E. et al . Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.  J Hypertens. 2001;  19 1349-1358
• 9 Stamler J, Stamler R, Neaton J D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data.  Arch Intern Med. 1993;  153 598-615
• 10 Wolf-Maier K, Cooper R S, Banegas J R. et al . Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.  JAMA. 2003;  289 2363-2369